WO1999041374A3 - Human short-chain tnf-receptor family protein - Google Patents

Human short-chain tnf-receptor family protein Download PDF

Info

Publication number
WO1999041374A3
WO1999041374A3 PCT/US1999/002570 US9902570W WO9941374A3 WO 1999041374 A3 WO1999041374 A3 WO 1999041374A3 US 9902570 W US9902570 W US 9902570W WO 9941374 A3 WO9941374 A3 WO 9941374A3
Authority
WO
WIPO (PCT)
Prior art keywords
receptor family
family protein
human short
sctr
chain tnf
Prior art date
Application number
PCT/US1999/002570
Other languages
French (fr)
Other versions
WO1999041374A2 (en
Inventor
Y Tom Tang
Neil C Corley
Preeti Lal
Original Assignee
Incyte Pharma Inc
Y Tom Tang
Neil C Corley
Preeti Lal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharma Inc, Y Tom Tang, Neil C Corley, Preeti Lal filed Critical Incyte Pharma Inc
Priority to EP99905816A priority Critical patent/EP1054961A2/en
Priority to AU25893/99A priority patent/AU2589399A/en
Priority to JP2000531555A priority patent/JP2002503464A/en
Priority to CA002321105A priority patent/CA2321105A1/en
Publication of WO1999041374A2 publication Critical patent/WO1999041374A2/en
Publication of WO1999041374A3 publication Critical patent/WO1999041374A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention provides a human short-chain TNF-receptor family protein (SCTR) and polynucleotides which identify and encode SCTR. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of SCTR.
PCT/US1999/002570 1998-02-17 1999-02-05 Human short-chain tnf-receptor family protein WO1999041374A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP99905816A EP1054961A2 (en) 1998-02-17 1999-02-05 Human short-chain tnf-receptor family protein
AU25893/99A AU2589399A (en) 1998-02-17 1999-02-05 Human short-chain tnf-receptor family protein
JP2000531555A JP2002503464A (en) 1998-02-17 1999-02-05 Human short chain TNF receptor family protein
CA002321105A CA2321105A1 (en) 1998-02-17 1999-02-05 Human short-chain tnf-receptor family protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2480898A 1998-02-17 1998-02-17
US09/024,808 1998-02-17

Publications (2)

Publication Number Publication Date
WO1999041374A2 WO1999041374A2 (en) 1999-08-19
WO1999041374A3 true WO1999041374A3 (en) 1999-09-23

Family

ID=21822505

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/002570 WO1999041374A2 (en) 1998-02-17 1999-02-05 Human short-chain tnf-receptor family protein

Country Status (5)

Country Link
EP (1) EP1054961A2 (en)
JP (1) JP2002503464A (en)
AU (1) AU2589399A (en)
CA (1) CA2321105A1 (en)
WO (1) WO1999041374A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2390438A1 (en) * 1999-11-12 2001-05-17 Human Genome Sciences, Inc. 19 human secreted proteins
WO2004004649A2 (en) * 2002-07-08 2004-01-15 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
EP2492281B1 (en) * 2009-10-19 2018-04-11 HanAll Biopharma Co., Ltd. Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
WO2011068993A1 (en) 2009-12-02 2011-06-09 Acceleron Pharma Inc. Compositions and methods for increasing serum half-life of fc fusion proteins.
WO2012087017A2 (en) * 2010-12-23 2012-06-28 한올바이오파마주식회사 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and method for preparing same
US8883982B2 (en) 2011-06-08 2014-11-11 Acceleron Pharma, Inc. Compositions and methods for increasing serum half-life

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0784093A1 (en) * 1995-12-22 1997-07-16 Amgen Inc. Osteoprotegerin
WO1997033904A1 (en) * 1996-03-12 1997-09-18 Human Genome Sciences, Inc. Death domain containing receptors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0784093A1 (en) * 1995-12-22 1997-07-16 Amgen Inc. Osteoprotegerin
WO1997033904A1 (en) * 1996-03-12 1997-09-18 Human Genome Sciences, Inc. Death domain containing receptors

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHINNAIYAN A M ET AL: "SIGNAL TRANSDUCTION BY DR3, A DEATH DOMAIN-CONTAINING RECEPTOR RELATED TO TNFR-1 AND CD95", SCIENCE, vol. 274, no. 5289, 8 November 1996 (1996-11-08), pages 990 - 992, XP000676685, ISSN: 0036-8075 *
DATABASE GENBANK 18 April 1997 (1997-04-18), "EST100127; H. sapiens pancreas tumor I", XP002110904 *
DATABASE GENBANK 18 April 1997 (1997-04-18), "EST12383; H. sapiens uterus tumor I", XP002110905 *
MACFARLANE M ET AL: "IDENTIFICATION AND MOLECULAR CLONING OF TWO NOVEL RECEPTORS FOR THE CYTOTOXIC LIGAND TRAIL", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 41, 10 October 1997 (1997-10-10), pages 25417 - 25420, XP002065148, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
AU2589399A (en) 1999-08-30
EP1054961A2 (en) 2000-11-29
WO1999041374A2 (en) 1999-08-19
CA2321105A1 (en) 1999-08-19
JP2002503464A (en) 2002-02-05

Similar Documents

Publication Publication Date Title
WO1999061471A3 (en) Human transmembrane proteins
WO2000000610A3 (en) Human signal peptide-containing proteins
WO2001012662A3 (en) Membrane associated proteins
WO2000015793A3 (en) Human gpcr proteins
WO2000034477A3 (en) Neuron-associated proteins
WO2000021988A3 (en) Human ankyrin family protein
WO2000018922A3 (en) Human carbohydrate-associated proteins
WO1999058692A3 (en) Human apoptosis associated proteins
WO2000012711A3 (en) Human membrane channel proteins
WO2000029583A3 (en) Immunoglobulin superfamily proteins
WO2000017355A3 (en) Human cytoskeleton associated proteins
WO2001005970A3 (en) Gtp-binding protein associated factors
WO1999049038A3 (en) Human calcium-binding proteins
WO2001007612A3 (en) Receptors and associated proteins
WO2000014251A3 (en) Human transferase proteins
WO2000052151A3 (en) Human secretory proteins
WO2000000594A3 (en) Human transferases
WO1999058558A3 (en) Cell signaling proteins
WO1999061614A3 (en) Human socs proteins
WO2000031263A3 (en) Gtpase associated proteins
WO1999041373A3 (en) Human transport-associated molecules
WO1999038981A3 (en) Human protein kinase molecules
WO1999041374A3 (en) Human short-chain tnf-receptor family protein
WO2000065054A3 (en) Human membrane-associated proteins
WO2000003015A3 (en) Human transport protein homologs

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 531555

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref document number: 2321105

Country of ref document: CA

Ref country code: CA

Ref document number: 2321105

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1999905816

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999905816

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999905816

Country of ref document: EP